To demonstrate HPV prevalence and its genotype distributions in anal cancer in China and to describe demographic and clinical features of HPV-related anal cancer in China; To describe the epidemiological characteristics ,trends and of disease burden of anal cancer in China
Study Type
OBSERVATIONAL
Enrollment
300
Fudan University Shanghai Cancer Center
Shanghai, China
RECRUITINGPrevalence and types of distribution of HPV
Time frame: From enrollment to pre-treatment
Incidence of anal-cancers-associated complications
with or without HPV infection by subgroups of sex, age at diagnosis, sexual orientation, and stage at diagnosis (Stage I, II, III, IV, unknown)
Time frame: From enrollment to pre-treatment
Routine laboratory testing results
Time frame: From enrollment to pre-treatment
Incidence rates of anal cancer in China
overall and for 5-year calendar periods 2001-2005, 2006-2010, and 2011-2015
Time frame: From enrollment to pre-treatment
Mortality rate of anal cancer in China
overall and for 5-year calendar periods 2001-2005, 2006-2010, and 2011-2015
Time frame: From enrollment to pre-treatment
Annual percentage changes (APCs) and average APCs (AAPCs)
Time frame: From enrollment to pre-treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.